Indaptus Therapeutics
INDP----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Indaptus Therapeutics(INDP) the EBIT is -2.16 M (+52.77%);the EPS is -0.232 (+97.45%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B52.77%
----
----
EPS
-0.231997.45%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf